HARTFORD, CT- With precision medicine becoming big business in Connecticut, the Commerce Committee has produced bipartisan proposals to coordinate efforts across the state, prepare Connecticut’s workforce and position Connecticut as a national leader in biomedical research.
Members of the committee today stressed the need for cooperative support from government, education and private business in growing Connecticut’s bioscience sector. The legislators highlighted several bills they intend to support, and called for continued cooperation between the University of Connecticut, Yale University, The Jackson Laboratory and other stakeholders.
“The Connecticut Health Data Collaborative has identified precision medicine and personalized health as a sector in Connecticut with tremendous power and potential,” said Senate President Pro Tempore Martin M. Looney (D-New Haven). “This group has proven to be critical in the advancement of our bioscience sector across the state and we need to continue encouraging that kind of cooperation between stakeholders. The Yale Center for Genomic Analysis, The Jackson Laboratory, Mount Sinai Genetic Testing Laboratory, the University of Connecticut, our hospitals, and insurance companies are pieces of a gathering critical mass of bioscience and precision medicine organizations throughout Connecticut will have strong and positive reverberations across the state. Establishing Connecticut as a hub for bioscience research and development will continue to attract and increase a skilled international and national bioscience workforce.”
“Connecticut is locked in a global competition to create good-paying jobs and support high-growth industries,” said Senate Majority Leader Bob Duff (D-Norwalk). “Our talented, hardworking, Continue reading BiPartisan Effort To Make Connecticut Biomedical Research Leader